Epana Bio

Berkeley, CA · Founded 2024 · Privately Held (backing)

Developer of targeted therapeutic systems designed for autoimmune disease treatment. Epana Bio is based in Berkeley, CA and was founded in 2024. Its last reported valuation was $27 million in Mar 2025. It has raised $14 million.

Last reported valuation
$27.0M
Oct 2026
Priced at
—
Total raised
$14.0M
Last round
—

Who backs Epana Bio?

12 investors
InvestorType
Impact AssetsOther
South Park CommonsVenture capital
Hummingbird VenturesOther
Refactor CapitalVenture capital
Tao Capital PartnersVenture capital
Dimension (United States)Venture capital
82VS—
Breakout Ventures—
F4 Fund—
KdT Ventures—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Epana Bio investors

12 investors are on record for Epana Bio, including Impact Assets, South Park Commons, Hummingbird Ventures and Refactor Capital.

Free account
More of Epana Bio with a free account
  • ·The complete investor list: 12 names
  • ·Watch Epana Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Epana Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View